Literature DB >> 11404298

Small bowel motility and colonic transit are altered in dogs with moderate renal failure.

H P Lefebvre1, J P Ferré, A D Watson, C A Brown, J P Serthelon, V Laroute, D Concordet, P L Toutain.   

Abstract

Although gastrointestinal complications are common in patients with renal disease, the effects of renal dysfunction on bowel motility and gut transit times are not well known. We assessed gastrointestinal electromyographic activity, gastric emptying rate, orocolonic transit time, oroanal transit time, and xylose absorption before and after surgically inducing a 66% decrease in glomerular filtration rate in dogs. Moderate renal failure induced no gross or microscopic gastrointestinal lesions but caused a 16-42% increase in gastrointestinal motility indexes. We found a 24% decrease in the propagation velocity of the myoelectrical migrating complex in the duodenojejunal segment, a 30% decrease in phase I duration in duodenal and jejunal regions, a 20% increase in the total irregular electrical activity of the small intestine, and a 22% increase in duration of the meal response in the duodenum and jejunum. Renal failure did not change xylose absorption, gastric emptying rate, and orocolonic transit time but decreased colonic transit time by 38%. The mean weight of feces was increased. These results indicate that moderate renal failure alters duodenojejunal motility and decreases colonic transit time.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11404298     DOI: 10.1152/ajpregu.2001.281.1.R230

Source DB:  PubMed          Journal:  Am J Physiol Regul Integr Comp Physiol        ISSN: 0363-6119            Impact factor:   3.619


  8 in total

1.  Fecal microbiota analysis of polycystic kidney disease patients according to renal function: A pilot study.

Authors:  Rabi Yacoub; Girish N Nadkarni; Daniel I McSkimming; Lee D Chaves; Sham Abyad; Mark A Bryniarski; Amanda M Honan; Shruthi A Thomas; Madan Gowda; John C He; Jaime Uribarri
Journal:  Exp Biol Med (Maywood)       Date:  2018-12-12

Review 2.  The gut microbiome, kidney disease, and targeted interventions.

Authors:  Ali Ramezani; Dominic S Raj
Journal:  J Am Soc Nephrol       Date:  2013-11-14       Impact factor: 10.121

3.  Determinants of gastrointestinal complications in cardiac surgery.

Authors:  Giuseppe D'Ancona; Richard Baillot; Brigitte Poirier; Francois Dagenais; José Ignacio Saez de Ibarra; Richard Bauset; Patrick Mathieu; Daniel Doyle
Journal:  Tex Heart Inst J       Date:  2003

4.  [Abdominal complications associated with cardiac surgery. Review of a contemporary surgical experience and of a series done without extracorporeal circulation].

Authors:  Brigitte Poirier; Richard Baillot; Richard Bauset; François Dagenais; Patrick Mathieu; Serge Simard; Brigitte Dionne; Manon Caouette; Frédéric-Simon Hould; Daniel Doyle; Paul Poirier
Journal:  Can J Surg       Date:  2003-06       Impact factor: 2.089

5.  Chronic kidney disease, uremic milieu, and its effects on gut bacterial microbiota dysbiosis.

Authors:  Lee D Chaves; Daniel I McSkimming; Mark A Bryniarski; Amanda M Honan; Sham Abyad; Shruthi A Thomas; Steven Wells; Michael Buck; Yijun Sun; Robert J Genco; Richard J Quigg; Rabi Yacoub
Journal:  Am J Physiol Renal Physiol       Date:  2018-04-25

Review 6.  Gut-Kidney Axis Investigations in Animal Models of Chronic Kidney Disease.

Authors:  Piotr Bartochowski; Nathalie Gayrard; Stéphanie Bornes; Céline Druart; Angel Argilés; Magali Cordaillat-Simmons; Flore Duranton
Journal:  Toxins (Basel)       Date:  2022-09-07       Impact factor: 5.075

7.  Pharmacokinetics of dolutegravir in HIV-seronegative subjects with severe renal impairment.

Authors:  Stephen Weller; Julie Borland; Shuguang Chen; Mark Johnson; Paul Savina; Brian Wynne; Toshihiro Wajima; Amanda F Peppercorn; Stephen C Piscitelli
Journal:  Eur J Clin Pharmacol       Date:  2013-10-06       Impact factor: 2.953

8.  Distal Colon Motor Dysfunction in Mice with Chronic Kidney Disease: Putative Role of Uremic Toxins.

Authors:  Elsa Hoibian; Nans Florens; Laetitia Koppe; Hubert Vidal; Christophe O Soulage
Journal:  Toxins (Basel)       Date:  2018-05-16       Impact factor: 4.546

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.